Valitse alueesi

Valitse alue, joka parhaiten vastaa sijaintiasi tai mieltymyksiäsi.

Valitse sivuston kieli

Tämä asetus hallitsee käyttöliittymän kieltä, mukaan lukien painikkeet, valikot ja kaikki sivuston tekstit. Valitse haluamasi kieli parhaan selauskokemuksen saamiseksi.

Valitse kielet työpaikkailmoituksille

Valitse kielet työpaikkailmoituksille, jotka haluat nähdä. Tämä asetus määrittää, mitkä työpaikkailmoitukset näytetään sinulle.

PhD project on nuclear metabolism in tumour hypoxia
KU Leuven

PhD project on nuclear metabolism in tumour hypoxia

2026-06-15 (Europe/Brussels)
Tallenna työpaikka

Tietoja työnantajasta

KU Leuven is an autonomous university. It was founded in 1425. It was born of and has grown within the Catholic tradition.

Käy työnantajan sivulla

We are seeking a highly motivated PhD candidate to join a joint KU Leuven – UCLouvain doctoral programme investigating compartmentalised metabolism in tumour hypoxia, at the interface between nuclear metabolism, chromatin regulation, and single-cell epigenomics in cancer.

The candidate will be co-supervised by Dr. Roxane Verdikt and Prof. Bernard Thienpont (Laboratory for Functional Epigenetics, KU Leuven) and Prof. Guido Bommer (Metabolic Research Group, de Duve Institute, UCLouvain),
with research activities shared between both institutions. KU Leuven (Leuven) and UCLouvain (Brussels) are located approximately
30 minutes apart and offer access to a highly collaborative and internationally recognised biomedical research environment.
Website unit

Project

The project will combine molecular and cellular biology, metabolic approaches, and functional genomics to study how tumour hypoxia reshapes nuclear metabolic pathways and epigenetic regulation.

Profile

We are looking for candidates with:
  • a Master’s degree in biochemistry, molecular biology, biomedical sciences, or bioengineering;
  • hands-on experience with mammalian cell culture and standard molecular biology techniques;
  • strong scientific curiosity and motivation for fundamental cancer research;
  • excellent communication and organisational skills.
Experience with epigenomics, omics data analysis, cancer models, or metabolic assays is considered an asset.

Offer

The successful candidate will be jointly enrolled at KU Leuven and UCLouvain and will benefit from the complementary expertise, infrastructure, and scientific communities of both institutions.
The position will remain open until filled. Applications should include:
  • a CV,
  • a short motivation letter,
  •  contact information for 2 referees,
  • and, optionally, a brief description of previous research experience or technical expertise relevant to the project.

Interested?

For more information please contact Dr. Roxane Verdikt, mail: [email protected] or Prof. dr. Bernard Thienpont, mail: [email protected].

KU Leuven strives for an inclusive, respectful and socially safe environment. We embrace diversity among individuals and groups as an asset. Open dialogue and differences in perspective are essential for an ambitious research and educational environment. In our commitment to equal opportunity, we recognize the consequences of historical inequalities. We do not accept any form of discrimination based on, but not limited to, gender identity and expression, sexual orientation, age, ethnic or national background, skin colour, religious and philosophical diversity, neurodivergence, employment disability, health, or socioeconomic status. For questions about accessibility or support offered, we are happy to assist you at this email address.

Lisätietoa työpaikasta

Otsikko
PhD project on nuclear metabolism in tumour hypoxia
Työnantaja
Sijainti
Oude Markt 13 Leuven, Belgia
Julkaistu
2026-05-09
Viimeinen hakupäivä
2026-06-15 23:59 (Europe/Brussels)
2026-06-15 23:59 (CET)
Työpaikan tyyppi
Tallenna työpaikka

Jobs from this employer

Näytetään työpaikkoja kielillä Englanti, italialainen Muuta asetuksia